Virtus ETF Advisers LLC Gemini Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

  • $206 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.39 - $4.0 $44,700 - $74,812
-18,703 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.3 - $6.32 $3,201 - $6,130
-970 Reduced 4.93%
18,703 $76,000
Q2 2021

Aug 10, 2021
BUY
$6.32 - $14.02 $124,333 - $275,815
19,673 New
19,673 $127,000

Others Institutions Holding GMTX

# of Institutions
1
Shares Held
2.44M
Call Options Held
0
Put Options Held
0
View Full List

About Gemini Therapeutics, Inc.

GMTX Quotes by TradingView
  • Ticker GMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,244,500
  • Market Cap $1.05B
  • Description
  • Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...
More about GMTX
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email